Nature Communications (Oct 2021)

Miniature type V-F CRISPR-Cas nucleases enable targeted DNA modification in cells

  • Greta Bigelyte,
  • Joshua K. Young,
  • Tautvydas Karvelis,
  • Karolina Budre,
  • Rimante Zedaveinyte,
  • Vesna Djukanovic,
  • Elizabeth Van Ginkel,
  • Sushmitha Paulraj,
  • Stephen Gasior,
  • Spencer Jones,
  • Lanie Feigenbutz,
  • Grace St. Clair,
  • Pierluigi Barone,
  • Jennifer Bohn,
  • Ananta Acharya,
  • Gina Zastrow-Hayes,
  • Selgar Henkel-Heinecke,
  • Arunas Silanskas,
  • Ralf Seidel,
  • Virginijus Siksnys

DOI
https://doi.org/10.1038/s41467-021-26469-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 8

Abstract

Read online

Miniature Cas12f editing systems are well suited for in vivo editing applications. Here the authors characterize the intrinsic activity of SpCas12f1 in plant and animal cells.